对卡拉-阿扎尔的药物改用
Biljana Arsić1,2, Budimir S Ilić3, Andreas Maier2
1Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia.
Pharmaceutics
|August 28, 2025
概括
这项研究探讨了对内脏莱什曼病 (VL) 的药物重新定位,确定了恩特卡维尔,瓦尔甘西克洛维尔和尼福洛为有前途的候选药物. 这些药物针对寄生虫和宿主通路, 为这种被忽视的热带疾病提供了一种新的治疗策略.
科学领域:
- 计算药物发现
- 寄生虫学
- 药理学
背景情况:
- 由于当前治疗方法的局限性,包括毒性和疗效问题,内脏性莱什曼病 (VL) 构成了全球重大健康挑战.
- 现有的VL疗法往往会导致免疫抑制并发症,因此需要开发更安全,更有效的治疗方案.
- 需要新的治疗策略,以向VL病变的寄生虫和宿主因素.
研究的目的:
- 通过向寄生虫特异性和宿主相关机制,识别和描述用于内脏病的药物.
- 采用互补的式药物再利用策略,包括EIIP选,分子对接和基于网络的分析.
- 通过分子动力学模拟来验证潜在的药物候选物,并评估它们的药物动力学特性.
主要方法:
- 电子离子相互作用潜力 (EIIP) 选和分子对接向 *Leishmania donovani* Rab5a 和氨酸还原酶 1 (PTR1).
- 使用Drugst.One平台进行基于网络的药物再利用,专注于STAT3相关基因网络.
- 用于复杂验证的分子动力学 (MD) 模拟和用于药物动力学评估的ADMET分析.
主要成果:
- 恩特卡维尔和瓦尔甘西克洛维尔对*L. donovani* Rab5a和PTR1具有强烈的结合 afinity,这表明它们具有重定向的潜力.
- 网络分析发现nifuroxazide是向宿主JAK2/ TYK2- STAT3轴的最佳候选物,MD模拟证实其高稳定性.
- 尼福洛胺表现出良好的ADMET特征,包括良好的口服生物可用性和膜透性,没有PINS警报.
结论:
- 关氨酸类型 (恩特卡维尔,瓦尔根西克洛维尔) 和酸衍生物尼福洛克萨齐德作为多重向药物重新定位候选药物具有前景.
- 这些候选药物通过向寄生虫生物学和宿主免疫调节提供双重治疗策略.
- 需要进行进一步的临床前研究,以评估这些重新定位的药物的疗效和安全性.
更多相关视频
相关概念视频
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...